West Pharmaceutical Services Sustainability Profile
West Pharmaceutical Services, Inc., commonly referred to as West, is a leading provider of innovative solutions for injectable drug delivery and containment. Headquartered in the United States, West operates extensively across major regions, including Europe and Asia, serving a global clientele in the pharmaceutical and biotechnology industries. Founded in 1923, the company has achieved significant milestones, including advancements in drug delivery systems and the development of high-quality packaging solutions. West's core offerings include a range of primary packaging components, delivery systems, and contract manufacturing services, all designed to enhance the safety and efficacy of medications. What sets West apart is its commitment to quality and innovation, ensuring that its products meet the stringent demands of the healthcare sector. With a strong market position and a reputation for excellence, West continues to be a trusted partner for pharmaceutical companies worldwide.
DitchCarbon Score
How does West Pharmaceutical Services's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
West Pharmaceutical Services's score of 48 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
West Pharmaceutical Services's reported carbon emissions
In 2024, West Pharmaceutical Services, headquartered in the US, reported total carbon emissions of approximately 97,903,000 kg CO2e. This figure includes about 31,311,000 kg CO2e from Scope 1 emissions and about 66,576,000 kg CO2e from Scope 2 emissions. In comparison, the previous year, 2023, the company recorded total emissions of about 104,190,000 kg CO2e, with Scope 1 emissions at approximately 30,828,000 kg CO2e and Scope 2 emissions at around 73,173,000 kg CO2e. West Pharmaceutical Services has set ambitious climate commitments, aiming to reduce absolute emissions by 40% across all scopes by 2030. This target includes a specific focus on reducing Scope 1 and Scope 2 emissions by 40% as well. Additionally, the company has previously committed to a 10% reduction in absolute emissions for both Scope 1 and Scope 2 from 2019 to 2023, which they have been tracking. The company is also working towards achieving 50% renewable electricity and improving energy efficiency by 3% year-over-year as part of their long-term sustainability strategy. These initiatives reflect West Pharmaceutical Services's commitment to addressing climate change and reducing their carbon footprint in the pharmaceutical sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2011 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 28,699,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 118,243,000 | - | 000,000,000 | - | - | - | - | - | - | - | - | - |
How Carbon Intensive is West Pharmaceutical Services's Industry?
How Carbon Intensive is West Pharmaceutical Services's Location?
West Pharmaceutical Services's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
West Pharmaceutical Services has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Smith Plus Nephew
Frequently Asked Questions
Common questions about West Pharmaceutical Services's sustainability data and climate commitments